2023 SUMMIT ON CANCER HEALTH DISPARITIES: REFRAMING AND ADDRESSING BARRIERS TO ADOPTION OF PRECISION ONCOLOGY 2022 Seattle United States
This annual oncology conference, 2023 Summit on Cancer Health Disparities: Reframing and addressing barriers to adoption of precision oncology, will feature lectures, panel discussions and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss the factors leading to cancer health disparities and ways to overcome the impact of these factors to optimize outcomes of cancer patients.
SCHD23 is an accredited continuing education activity (CME activity) that will foster collaborative interdisciplinary interactions and partnerships to stimulate the development of new research and clinical practices that reduce cancer health disparities and improve outcomes of the diverse patient population.
TARGET AUDIENCE
- Oncologist and Hematologists
- Oncology and Hematology Nurse Practitioners
- Oncology and Hematology Physician Assistants
- Oncology and Hematology Nurses
- Oncology and Hematology Pharmacists
- Oncology and Hematology Fellows/Residents
- Oncology and Hematology Researchers
- Others interested in cancer disparities
LEARNING OBJECTIVES
Upon successful completion of this educational activity, participants will be able to:
- Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
- State the financial and physical barriers, review strategies to navigate these factors to optimize management of patients with cancer.
- Incorporate evidence-based strategies to minimize the impact of specific drivers of inequity in the management of patients with cancer.
- Describe challenges and develop novel approaches to improve participation of underrepresented communities in clinical trials.
2023 SUMMIT ON CANCER HEALTH DISPARITIES: REFRAMING AND ADDRESSING BARRIERS TO ADOPTION OF PRECISION ONCOLOGY 2022 Seattle United States
Submit your abstract to present at our 2023 Summit on Cancer Health Disparities (SCHD23) on April 28 to 30, 2023, at the Grand Hyatt Seattle.
The Abstract Submission Deadline is January 31, 2023.
We will accept abstracts in the following categories. Please select a category that fits the submission best when submitting the abstract.
- Technology
- Tumor biology
- Precision oncology
- Epidemiology
- Screening
- Health policy
- Survivorship
- Quality improvement
- Database analysis
- Encore abstracts: The abstract committee will accept encore clinical trials abstracts for this conference. Submissions with additional data that supplement the previous presentation will be preferred. Authors should provide information regarding the original presentation, including the name of the meeting where the abstract was originally presented.
Notifications – Authors will be notified of acceptance or rejection via email.
